Inovail

Inovail was a specialty pharmaceutical company focused on the commercialization of innovative healthcare products across the Asia-Pacific region. Headquartered in Singapore, the company specialized in therapeutic areas such as dermatology, complementary oncology, and female healthcare. Inovail operated as a key subsidiary of Invida Pharmaceutical Holdings, a joint venture between Temasek Holdings, Quintiles, and the Zuellig Group. In 2011, the company was acquired by the Menarini Group and subsequently integrated into Menarini Asia-Pacific. Its portfolio included notable products such as the Sancuso transdermal patch and OmegaGen krill oil supplements.